Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis

ClinicalTrials.gov ID: NCT06029972

Public ClinicalTrials.gov record NCT06029972. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 4:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-Blinded, Randomized, Placebo-Controlled, Dose-Ranging Study Evaluating the Efficacy and Safety of GS-5290 in Participants With Moderately to Severely Active Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this study is to learn if tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with moderate to severe ulcerative colitis. The study will compare participants in different treatment groups treated with tilpisertib fosmecarbil with participants treated with placebo. The primary objective of this study is to demonstrate the efficacy of tilpisertib fosmecarbil, compared to placebo control, in achieving Clinical Response at Week 12.

Study identification

NCT ID
NCT06029972
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
176 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 5, 2023 (Actual)
Primary completion
Jan 2027 (Estimated)
Completion
Feb 2028 (Estimated)
Last update posted
Sep 11, 2026

2023 – 2028

United States locations

U.S. sites
35
U.S. states
12
U.S. cities
32
Facility City State ZIP Site status
GI Alliance Sun City Arizona 85351 —
GastroSb Weight Loss Clinic Chula Vista California 91910 —
Southern California Research Centers Coronado California 92118 —
VVCRD Research Garden Grove California 92845 —
UC San Diego Health System La Jolla California 92037 —
Gastro Care Institute Lancaster California 93534 —
Om Research LLC Lancaster California 93534 —
University of California, Davis Sacramento California 95817 —
University of California San Francisco San Francisco California 94115 —
Luna Research Coral Gables Florida 33134 —
University of Florida Gainesville Florida 32610 —
The Medici Medical Research Hollywood Florida 33021 —
Clinical Research of Osceola Kissimmee Florida 34741 —
Florida Research Institute Largo Florida 33771 —
GI PROS Research Naples Florida 34102 —
Clinical One Research Orlando Florida 32807 —
Digestive and Liver Center of Florida, LLC Orlando Florida 32825 —
Advanced Medical Research Center Port Orange Florida 32127 —
Corewell Health Grand Rapids Michigan 49546 —
Mayo Clinic Rochester Minnesota 55905 —
Gastroenterology Associates of North Mississippi Oxford Mississippi 38655 —
Digestive Health Specialists Tupelo Mississippi 38801 —
St. Charles Clinical Research St Louis Missouri 63141 —
NYU Langone Long Island Clinical Research Associates Great Neck New York 11021 —
Gastroenterology & Hepatology Specialists Inc Canton Ohio 44718 —
The Ohio State University Wexner Medical Centre Columbus Ohio 43210 —
Skyline Gastroenterology of West Tennessee Jackson Tennessee 38301 —
Gastroenterology Research of Hill Country Boerne Texas 78006 —
GI Alliance Lubbock Texas 79410 —
Clinical Associates in Research Therapeutics of America San Antonio Texas 78212 —
Gastroenterology Research of San Antonio San Antonio Texas 78229 —
Tyler Research Institute, LLC Tyler Texas 75701 —
Gastroenterology Associates of Tidewater Chesapeake Virginia 23320 —
Emeritas Group Research Lansdowne Town Center Virginia 20176 —
Gastroenterology Consultants of Southwest Virginia Roanoke Virginia 24014 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 67 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06029972, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 11, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06029972 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →